About
I'm a biopharma correspondent at Endpoints News, focused on uncovering and explaining the…
Activity
-
For anyone in the PR world curious about what we're up to at Endpoints News, we'll be talking about it with Ticket to Biotech's Lynnea…
For anyone in the PR world curious about what we're up to at Endpoints News, we'll be talking about it with Ticket to Biotech's Lynnea…
Shared by Andrew Dunn
-
Back by popular demand, our next Press Pass Panel is here! In August we're hosting Andrew Dunn, Ryan McRae and Nicole Wetsman of Endpoints News to…
Back by popular demand, our next Press Pass Panel is here! In August we're hosting Andrew Dunn, Ryan McRae and Nicole Wetsman of Endpoints News to…
Liked by Andrew Dunn
-
Some exciting personal news: Today is my first day at FiscalNote! I'm joining CQ and Roll Call where I’ll be covering healthcare policy alongside a…
Some exciting personal news: Today is my first day at FiscalNote! I'm joining CQ and Roll Call where I’ll be covering healthcare policy alongside a…
Liked by Andrew Dunn
Experience & Education
-
Endpoints News
View Andrew’s full experience
See their title, tenure and more.
or
More activity by Andrew
-
There is a tremendous amount of froth in the AI space that is also bleeding into the techbio space. Much of it is about trying to predict the pace…
There is a tremendous amount of froth in the AI space that is also bleeding into the techbio space. Much of it is about trying to predict the pace…
Liked by Andrew Dunn
-
Hey, all #biotechies. Bob Langer will be joining me for a fireside and some networking at the Endpoints 11 dinner at The State Room September 26…
Hey, all #biotechies. Bob Langer will be joining me for a fireside and some networking at the Endpoints 11 dinner at The State Room September 26…
Liked by Andrew Dunn
-
For three and a half years, I followed teenager Connor Dalby and family while a custom treatment was developed for his seizures. Connor, after long…
For three and a half years, I followed teenager Connor Dalby and family while a custom treatment was developed for his seizures. Connor, after long…
Liked by Andrew Dunn
-
NEW: In the latest in a series on executive and employee pay, Kyle LaHucik and I analyzed so-called golden parachutes. These are special incentives…
NEW: In the latest in a series on executive and employee pay, Kyle LaHucik and I analyzed so-called golden parachutes. These are special incentives…
Shared by Andrew Dunn
-
In reviewing regulatory filings, Andrew Dunn pieced together a table that details the median employee pay at 177 biopharma…
In reviewing regulatory filings, Andrew Dunn pieced together a table that details the median employee pay at 177 biopharma…
Liked by Andrew Dunn
-
Salary and pay info is some of the most sensitive data for every industry. In my latest for Endpoints News, I compiled data on median employee pay…
Salary and pay info is some of the most sensitive data for every industry. In my latest for Endpoints News, I compiled data on median employee pay…
Shared by Andrew Dunn
-
NEW: Here are the 20 highest-paid CEOs biopharma for 2023. I analyzed proxy filings for over 500 life sciences companies, identifying the boards…
NEW: Here are the 20 highest-paid CEOs biopharma for 2023. I analyzed proxy filings for over 500 life sciences companies, identifying the boards…
Shared by Andrew Dunn
-
In today's Endpoints News health tech newsletter! - I ask Andreessen Horowitz what Talkiatry's plans to go public in wake of their big raise means…
In today's Endpoints News health tech newsletter! - I ask Andreessen Horowitz what Talkiatry's plans to go public in wake of their big raise means…
Liked by Andrew Dunn
-
In 2001, Vertex Pharmaceuticals paid $592 million in stock to acquire a tiny San Diego startup. That also brought in the biologist Paul Negulescu…
In 2001, Vertex Pharmaceuticals paid $592 million in stock to acquire a tiny San Diego startup. That also brought in the biologist Paul Negulescu…
Shared by Andrew Dunn
-
NEW: Formation Bio has raised a $372 million Series D, carrying a boost to its valuation that was already over $1 billion after its C round. I…
NEW: Formation Bio has raised a $372 million Series D, carrying a boost to its valuation that was already over $1 billion after its C round. I…
Shared by Andrew Dunn
-
This list has become a fantastic annual tradition at Endpoints News, started and led by my colleague Kyle LaHucik. Check out the 2024 version of…
This list has become a fantastic annual tradition at Endpoints News, started and led by my colleague Kyle LaHucik. Check out the 2024 version of…
Shared by Andrew Dunn
-
NEW: A group of ex-Meta scientists have raised a $142 million seed round to advance AI research, particularly a newly unveiled model that can…
NEW: A group of ex-Meta scientists have raised a $142 million seed round to advance AI research, particularly a newly unveiled model that can…
Shared by Andrew Dunn
-
One of the most fun chats (literally) I've recently had. Thanks for having me Andrew Dunn and for the introvert friendly medium.
One of the most fun chats (literally) I've recently had. Thanks for having me Andrew Dunn and for the introvert friendly medium.
Liked by Andrew Dunn
-
NEW: I invited Benchling CEO Sajith Wickramasekara to join our secret Slack channel to discuss the latest on the biotech market, his startup, and…
NEW: I invited Benchling CEO Sajith Wickramasekara to join our secret Slack channel to discuss the latest on the biotech market, his startup, and…
Shared by Andrew Dunn
Other similar profiles
-
Lei Lei Wu
Connect -
Drew Armstrong
Connect -
John Carroll
Connect -
Allison DeAngelis
Reporter at STAT
Connect -
Casey Ross
Technology Reporter at STAT News
Connect -
Matthew Herper
Connect -
Brian Gormley
Connect -
Arjun Murthy
AI-enabled BioPharma Market Intelligence | Ex. McKinsey | Yale MBA
Connect -
Don Kirkpatrick
Connect -
Vik Bajaj
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Andrew Dunn in United States
-
Andrew Dunn
VP of Procore Capital -- Tech-enabled working capital products for construction
-
Andrew Dunn
-
Andrew Dunn
-
Andrew Dunn
515 others named Andrew Dunn in United States are on LinkedIn
See others named Andrew Dunn